Trial
NCT03173092
A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Takeda
Collaborators
—
Condition
Multiple Myeloma
Intervention
Ixazomib
Why stopped
All participants on the study have concluded treatment, core study activities are complete, and the scientific goals of the study have been met.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-04